Global Cannabis Stocks Drop 10% in July

Cannabis stocks, as measured by the Global Cannabis Stock Index, fell again in July, declining 10.0% to 90.12 after posting a new 2018 low:

The index, which had 53 qualifying members that were equally weighted at the time of the prior rebalancing in June (now 52, after the removal on 7/26 of MedReleaf, which was acquired by Aurora Cannabis), declined 29.5% in the first six months of the year and has now decreased 36.6% in 2018. Despite the losses, the index is still up more than 58% since bottoming in late October.

Weakness among the Canadian LPs pressured the returns during the month. The index began the month with 71.7% of the composition in Canada, including 39.6% licensed producers. One stock listed on the Australian Stock Exchange accounted for 1.9%.

Only 8 companies posted gains:

CV Sciences (OTC: CVSI) pre-announced a very strong quarter during the month, with sales tripling. Hiku Brands (CSE: HIKU) (OTC: DJACF) terminated its merger agreement with WeedMD (TSXV: WMD) (OTC: WDDMF), opting instead to be acquired by Canopy Growth (TSX: WEED) (NYSE: CGC).

Nineteen companies posted declines in excess of 15%, with fifteen of them having primary listings in Canada, including 6 licensed producers, and one in Australia:

We criticized the accounting of PotNetwork Holdings (OTC: POTN) when it filed a Form 10 with the SEC during the month. After our report, the company withdrew its filing when its auditor lost its PCAOB certification.

We will summarize the index performance again in a month. You can learn more about the index members and the qualifications for inclusion by visiting the Global Cannabis Stock Index. Be sure to bookmark the page to stay current on cannabis stock price movements within the day or from day-to-day.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter